Moss Genomics Inc. — Investor Relations & Filings
Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research, dedicated to developing advanced genetic insights and personalized health solutions. The company's core offering is a blockchain-based platform designed for the private, secure storage and monetization of individual genomic data. Recent corporate strategy has emphasized significant integration with digital assets, positioning the company as a hybrid entity. This strategy includes substantial investments in Ethereum (ETH) and participation in cryptocurrency mining operations, such as Bitcoin Cash (BCH), alongside its consumer genomics initiatives.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-03-02 | English | |
| Interim MD&A - English.pdf | 2026-03-02 | English | |
| Interim financial statements/report – English.pdf | 2026-03-02 | English | |
| News release - English.pdf | 2026-01-05 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2025-12-02 | English | |
| Interim MD&A - English.pdf | 2025-12-01 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Keros Therapeutics, Inc.
Develops protein therapeutics for disorders linked to TGF-β…
|
KROS | US | Professional, scientific and te… |
|
KIM FOREST
Offers integrated precision medicine and molecular diagnost…
|
6645 | TW | Professional, scientific and te… |
|
Kura Oncology, Inc.
Clinical-stage biopharma company developing precision medic…
|
KURA | US | Professional, scientific and te… |
|
LAB Research Inc.
Global non-clinical CRO specializing in contract research, …
|
LRI | CA | Professional, scientific and te… |
|
Laekna, Inc.
Clinical-stage biotech developing novel therapies for oncol…
|
2105 | HK | Professional, scientific and te… |
|
Larimar Therapeutics, Inc.
A clinical-stage biotech developing treatments for complex …
|
LRMR | US | Professional, scientific and te… |
|
Lexaria Bioscience Corp.
A biotech company with a patented platform to improve oral …
|
LEXX | US | Professional, scientific and te… |
|
LigaChem Biosciences Inc.
Clinical-stage biopharma developing ADCs, immuno-oncology d…
|
141080 | KR | Professional, scientific and te… |
|
Linical Co., Ltd.
A global CRO providing a full spectrum of drug development …
|
2183 | JP | Professional, scientific and te… |
|
Lipigon Pharmaceuticals AB
A clinical-stage company developing therapeutics for lipid-…
|
LPGO | SE | Professional, scientific and te… |
Moss Genomics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/48378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=48378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=48378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=48378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 48378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moss Genomics Inc. (id: 48378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.